martes, 19 de noviembre de 2019

Inside STAT: Warren’s health care evolution earns friends on the left, foes back home

Morning Rounds
Shraddha Chakradhar

Inside STAT: Warren’s health care evolution earns friends on the left, foes back home


ELIZABETH WARREN SPEAKS TO VOTERS AT EXETER HIGH SCHOOL. (JESSICA RINALDI/THE BOSTON GLOBE)
In her bid for president, Elizabeth Warren has evolved from a Massachusetts senator sympathetic to her home state’s health care interests to a more national figure interested in broad, sweeping changes that go beyond what affects the Bay State. She helped write the landmark 21st Century Cures Act, which promised $5 billion in biomedical research, but when the time came to vote, hers was a resounding “no” because “Big Pharma got its handout,” she declared. Not only has she angered Massachusetts health industry leaders, but as a relatively late arrival to the progressive “Medicare for All” camp, fellow liberals are also questioning her bonafides. Read more from STAT’s Lev Facher and the Boston Globe’s Liz Goodwin.

No hay comentarios: